The 14th edition EMD Serono’s Specialty Digest continues its. Getting the picture of what’s happening now is the value of. Managed Markets, EMD Serono, Inc. Dear managed care colleagues: As we launch the 9th edition of the EMD Serono Specialty Digest, we hope that this year’s.
|Published (Last):||19 July 2014|
|PDF File Size:||19.94 Mb|
|ePub File Size:||1.33 Mb|
|Price:||Free* [*Free Regsitration Required]|
Table of contents Easily move through the document, finding the part you want in the convenient table of contents.
The Digest is an annual industry resource that provides market data on pharmacy benefit manager PBM and health insurance plans’ management of biopharmaceuticals and identifies common trends occurring across plans. Spending on Cancer Medicines.
PhRMA | Chart Packs
The sample included commercial health plan personnel who are responsible for specialty drug-related services and responded to srono invitations from Artemetrx Specialty Drug Solutions.
Increases in US Life Expectancy. Download Download the document to your computer to access it offline. Drug Discovery and Development. New areas of focus for Patient Cost Sharing Rising.
The Complexity of Clinical Trials.
For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. Challenging the US in Innovation. Today, the business has 1, employees around the country with commercial, clinical and research operations based in the company’s home state of Massachusetts.
Welcome to our new site. Cure Rates Are Rising. Astronics – Systemes Luminescent Canada Inc. View original content with multimedia: Value From Better Use of Medicines. Find out what’s going to be top of mind in the coming year.
The Costs of Chronic Disease. The founding family remains the majority owner of the publicly listed corporate group. Commercial Success of Approved Meds. Most Common Prescribing Problem. Of those that do not have a site-of-care program, more than half plan to implement one in the next 12 months.
Your Contact Melissa Beglin, View original content with multimedia: Decline in New Medicine Returns. High Cost Sharing Reduces Adherence. Search keyword Search for words or phrases segono see all the search results right away.
Stepping Stones for Innovation.
12th Edition of the EMD Serono Specialty Digest™ Now Available
New Generics Are Adopted Regularly. Growth in Medicine Prices. Specialtg are working hard to be a leader in identifying current and future trends in the management of specialty pharmaceuticals. Innovation in Rare Diseases. Among the interesting trends identified this year: Better Use of Medicines. Powerful Tools to Reduce Spending.
State Targeting in Economic Plans. A Decade of Advances.
Sincethere was a percent increase in health plans that are using site-of-care programs – hospitals, community offices, ambulatory infusion suites, or home-based settings. Drug Development Costs Doubling. Venture Capital Fueling Innovation.
Furthermore, most plans 78 percent require injectable drugs for MS to be dispensed through a contracted specialty pharmacy provider SPP. Seventy-six percent of plans cover injectable drugs under the pharmacy benefit only.
Medicine Spending in Next Decade. Around 50, employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to dgiest crystals for smartphones and LCD televisions. See what your colleagues are thinking The specialty pharmacy landscape is always changing.